Hemogenyx Pharmaceuticals Plc Stock
Stocks
SILF
GB00BQVXM815
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
London S.E.
11:35:19 2026-11-04 EST
|
5-day change | 1st Jan Change | ||
| 605.00 GBX | -5.47% |
|
-10.10% | +5.77% |
| 10-19 | Cora Gold shareholder Eagle Eye restructures holding | AN |
| 10-19 | Hemogenyx Pharmaceuticals Partners with Nitto Denko to Explore CAR mRNA's Lipid Nanoparticle Delivery | MT |
| Market Cap | 43.52M 58.6M 52.22M 47.89M 81.81M 5.54B 83.68M 572M 229M 2.93B 220M 215M 9.29B | P/E 2024 |
-2.38x | P/E 2025 | -2.6x |
|---|---|---|---|---|---|
| Enterprise Value | 43.94M 59.16M 52.72M 48.35M 82.6M 5.59B 84.49M 578M 232M 2.96B 222M 217M 9.37B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
70.98% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SILF | Delayed | |
Deutsche Boerse AG
| 5HU0 | Delayed | |
|
Börse Stuttgart
| 5HU0 | Delayed |
| 1 day | -5.47% | ||
| 1 week | -10.10% | ||
| Current month | +6.89% | ||
| 1 month | -13.57% | ||
| 3 months | -7.49% | ||
| 6 months | -11.03% | ||
| Current year | +5.77% |
| 1 week | 530 |  | 728.64 |
| 1 month | 530 | | 799 |
| Current year | 430 | | 1,220 |
| 1 year | 356 | | 1,220 |
| 3 years | 124 | | 2,853.6 |
| 5 years | 124 | | 2,853.6 |
| 10 years | 124 | | 6,155 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 2017-10-03 | |
Elina Shrestha
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2017-10-03 | |
Alexis Sandler
BRD | Director/Board Member | - | 2017-10-03 |
Peter Redmond
BRD | Director/Board Member | 78 | 2017-10-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/29/26 | Free | Director | 300,000 | 4.4118% | ||
| 5/29/26 | Free | Founder | 300,000 | 4.4118% | ||
| 5/29/26 | Free | Founder | 300,000 | 4.4118% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.47% | -10.10% | -20.81% | -27.11% | 58.39M | |
| +10.00% | +5.18% | +54.35% | +71.20% | 60.57B | |
| +1.44% | +5.05% | +22.52% | +99.64% | 55.51B | |
| +3.32% | +2.31% | +11.04% | +76.48% | 55.22B | |
| +1.29% | -4.80% | +25.92% | +33.89% | 43.27B | |
| +5.51% | +0.41% | +21.25% | +91.14% | 40.36B | |
| +1.90% | +4.92% | +238.06% | +819.22% | 41.63B | |
| -3.79% | -7.50% | +89.46% | +78.72% | 33.29B | |
| +5.32% | +6.04% | +20.27% | +52.98% | 32.27B | |
| +3.57% | +11.29% | -40.95% | +352.71% | 22.91B | |
| Average | +2.40% | +4.06% | +42.11% | +164.89% | 38.51B | |
| Weighted average by Cap. | +3.61% | +4.06% | +51.25% | +170.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -5.62M -7.57M -6.74M -6.18M -10.56M -715M -10.8M -73.9M -29.63M -378M -28.4M -27.79M -1.2B | -9.76M -13.14M -11.71M -10.74M -18.35M -1.24B -18.77M -128M -51.46M -657M -49.33M -48.28M -2.08B |
| Net Debt | 2.46M 3.32M 2.96M 2.71M 4.63M 314M 4.74M 32.4M 12.99M 166M 12.45M 12.19M 526M | 418K 563K 501K 460K 785K 53.17M 803K 5.49M 2.2M 28.14M 2.11M 2.07M 89.15M |
Employees
16
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-04 | GBX 605.00 | -5.47% | 3,930 |
| 26-11-03 | GBX 640.00 | +5.96% | 9,685 |
| 26-11-02 | GBX 604.00 | +6.71% | 25,061 |
| 26-10-30 | GBX 566.00 | -16.76% | 29,625 |
| 26-10-29 | GBX 680.00 | +1.04% | 9,400 |
- Stock Market
- Stocks
- SILF Stock
Select your edition
All financial news and data tailored to specific country editions
